The hematology specialist officially diagnosed me with Gaucher disease. The bone marrow biopsy confirmed my diagnosis of ...
Find effective medications for 'Gaucher’s Disease treatment right here!' This page is a trusted source for both professionals and patients, detailing brand-name and generic options designed to ...
England’s NHS will routinely fund Sanofi/Genzyme’s Cerdelga (eliglustat) for the rare condition Gaucher disease after a recommendation from NICE. The cost effectiveness body published final ...
Additional details on the meeting can be found at the WORLD Symposium website. About Spur Therapeutics Spur Therapeutics is a clinical-stage biotechnology company focused on developing life-changing ...
Sanofi is still running studies of the glycosphingolipid (GSL) inhibitor in rare lysosomal storage diseases like Gaucher disease type 3, Fabry disease and GM2 gangliosidosis (also known as Tay ...
and congenital neurogenic diabetes insipidus), and lysosomal storage disorders (Gaucher's disease type I, Fabry disease, mucopolysaccharidosis I, mucopolysaccharidosis II, mucopolysaccharidosis VI ...
NIMHANS hosts ISHG meet to foster innovation for domestic and global healthcare solutions: Our Bureau, Bengaluru Tuesday, January 21, 2025, 10:00 Hrs [IST] National Institute of M ...